Though not statistically significant, the overall data supports a trend where anti-TGF-β intervention could effectively restructure the highly fibrotic microenvironment in HCC and allow T cell infiltration within the tumor. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.